Schedule of Warrants Activity (Details) - Warrant [Member] |
6 Months Ended |
|---|---|
|
Jun. 30, 2022
$ / shares
shares
| |
| Accumulated Other Comprehensive Income (Loss) [Line Items] | |
| Number of shares of common stock issuable for warrants, beginning balance | 54,280,658 |
| Weighted average exercise price, beginning balance | $ / shares | $ 1.43 |
| Number of shares of common stock issuable for warrants, expiration of warrants | (33,601,204) |
| Weighted average exercise price expiration of warrants | $ / shares | $ 0.3526 |
| Increase in number of shares of common stock issuable under warrants during the period as a result of down round provisions | 511,312,671,643 |
| Number of shares of common stock issuable for warrants, ending balance | 511,333,351,097 |
| Weighted average exercise price, ending balance | $ / shares | $ 0.00013 |
| X | ||||||||||
- Definition Expiration of warrants. No definition available.
|
| X | ||||||||||
- Definition Weighted average exercise price, warrants outstanding. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements for which rights to exercise lapsed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Increase (decrease) in the number of shares under non-option equity instrument agreements. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|